AdJane Unveils mRNA Mucosal Booster Vaccine Strategy
Delft, The Netherlands, September 10, 2026 AdJane Biosciences has announced the publication of a new white paper, “Boosting mRNA:...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
Delft, The Netherlands, September 10, 2026 AdJane Biosciences has announced the publication of a new white paper, “Boosting mRNA:...
WASHINGTON, May 13, 2026 The Sabin Vaccine Institute honored renowned vaccine researchers Professor Uğur Şahin and Professor Özlem Türeci...
